All In Biotech

Drug Trial Radar · NCT07476287

Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer

A PHASE 2 INTERVENTIONAL STUDY OF PF-08634404 IN COMBINATION WITH CHEMOTHERAPY IN PARTICIPANTS WITH PREVIOUSLY UNTREATED TRANSFORMED SMALL CELL LUNG CANCER

Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

40

Planned (sponsor's estimate)

Start

Jul 2, 2026

Primary completion

Mar 24, 2028

Study completion Mar 24, 2031

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
Mar 17, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is being done to learn more about a new medicine called PF-08634404. The study team wants to understand how well PF-08634404 works when given alone or with chemotherapy . Chemotherapy is a type of cancer treatment that uses medicines to destroy cancer cells or stop them from growing. The study is for adults with Transformed Small Cell Lung Cancer (T-SCLC ). T SCLC is a rare lung cancer that happens when one type of lung cancer changes into a more aggressive type after treatment stops working. To join the study, participants must meet the following conditions: * Are aged 18 years or older * Diagnosed with T-SCLC and have not received treatment for this type of lung cancer (a single cycle of chemotherapy may be permitted) * Prior diagnosis of epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer treated with tyrosine kinase inhibitors (TKIs) * Have healthy organs based on medical tests and are in good physical condition After joining the study, adults will be given chemotherapy in addition to the study medicine. After this combination treatment is finished, the study medicine will be continued alone. Adults will receive the treatment through IV infusions (medicine given directly into a vein). All treatments will be done at clinical study sites, where a trained medical team will monitor adults during and after each visit.

Conditions

  • Small Cell Lung Cancer
  • Small Cell Lung Cancer ( SCLC )
  • Transformed Small Cell Lung Cancer
  • Lung Neoplasms
  • Carcinoma, Small Cell Lung
  • Small Cell Cancer Of The Lung

Interventions

  • PF-08634404Drug

    Concentrate for solution for infusion

  • ChemotherapyDrug

    Injection for intravenous use

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Confirmed Objective Response Rate (ORR) as assessed by investigator based on Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST v1.1)Time frame: From start of treatment until first documented CR or PR (approximately maximum up to 1 years)
  2. Number of Participants with Adverse Events (AEs)Time frame: Up to 90 days after the last dose of treatment

Locations

75 sites in 12 countries. Site status is shown where the registry gives one.

  • City of Hope National Medical Center

    Duarte, California · Recruiting

  • UC San Diego Medical Center - Encinitas

    Encinitas, California · Recruiting

  • City of Hope Lennar Foundation Cancer Center

    Irvine, California · Recruiting

  • UC San Diego Koman Family Outpatient Pavilion

    La Jolla, California · Recruiting

  • UC San Diego Medical Center - La Jolla (Jacobs Medical Center / Thornton Pavilion)

    La Jolla, California · Recruiting

  • UC San Diego Moores Cancer Center

    La Jolla, California · Recruiting

  • UC San Diego Sulpizio Cardiovascular Center

    La Jolla, California · Recruiting

  • UC San Diego Medical Center - Bankers Hill

    San Diego, California · Recruiting

  • UC San Diego McGrath Outpatient Pavilion - Hillcrest

    San Diego, California · Recruiting

  • UC San Diego Medical Center- Hillcrest

    San Diego, California · Recruiting

  • UC San Diego Medical Center - Rancho Bernardo

    San Diego, California · Recruiting

  • UC San Diego Medical Center - Vista

    Vista, California · Recruiting

  • Sylvester Comprehensive Cancer Center - The Lennar Foundation Medical Center

    Coral Gables, Florida · Recruiting

  • Sylvester Comprehensive Cancer Center- Doral

    Doral, Florida · Recruiting

  • Sylvester Comprehensive Cancer Center

    Miami, Florida · Recruiting

  • University of Miami Hospital and Clinics

    Miami, Florida · Recruiting

  • Sylvester Comprehensive Cancer Center- Kendall

    Miami, Florida · Recruiting

  • Sylvester Comprehensive Cancer Center - Sole Mia

    North Miami, Florida · Recruiting

  • Hope and Healing Clinical Research

    Hinsdale, Illinois · Recruiting

  • Hope and Healing Clinical Research

    New Lenox, Illinois · Recruiting

  • Brigham and Women's Hospital

    Boston, Massachusetts · Not yet recruiting

  • Dana-Farber Cancer Institute

    Boston, Massachusetts · Not yet recruiting

  • Dana-Farber Cancer Institute -Chestnut Hill

    Newton, Massachusetts · Not yet recruiting

  • MSK Basking Ridge

    Basking Ridge, New Jersey · Recruiting

  • MSK Monmouth

    Middletown, New Jersey · Recruiting

  • MSK Bergen.

    Montvale, New Jersey · Recruiting

  • MSK Commack

    Commack, New York · Recruiting

  • MSK Westchester

    Harrison, New York · Recruiting

  • Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy

    Long Island City, New York · Recruiting

  • Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street).

    New York, New York · Recruiting

  • Memorial Sloan Kettering Cancer Center

    New York, New York · Recruiting

  • MSK Nassau

    Uniondale, New York · Recruiting

  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio · Not yet recruiting

  • Westmead Hospital

    Westmead, New South Wales, Australia · Recruiting

  • Calvary Connery Centre

    Elizabeth Vale, South Australia, Australia · Recruiting

  • Warringal Private Hospital

    Heidelberg, Victoria, Australia · Recruiting

  • Hospital São Lucas da PUCRS

    Porto Alegre, Brazil · Recruiting

  • Hospital Sírio Libanês

    São Paulo, Brazil · Recruiting

  • Centro Paulista de Oncologia Clínica

    São Paulo, Brazil · Recruiting

  • Hospital Beneficência Portuguesa de São Paulo

    São Paulo, São Paulo, Brazil · Recruiting

Showing 40 of 75 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.